Literature DB >> 8620446

Effect of tamoxifen on intraperitoneal N-nitroso-N-methylurea induced tumors.

G Martin1, G Melito, E Rivera, E Levin, C Davio, G Cricco, N Andrade, R Caro, R Bergoc.   

Abstract

The effect of tamoxifen (TAM) was evaluated on a mammary tumor model induced in Sprague-Dawley rats by intraperitoneal administration of three N-nitroso-N-methylurea (NMU) doses. Animals received TAM (1 mg/kg per day) from 10 days before the first NMU dose up to 140 days later. Thereafter, treatment was discontinued and the observation period was extended 60 days longer. Mean overall latency period, tumor number per rat and tumor incidence were recorded. Significant differences between treated and control batches were observed in tumor number per rat (1.8 +/- 1.1 versus 5.2 +/- 1.6; P < 0.05) and in tumor incidence (50% versus 100%; P < 0.05), respectively. No significant difference in latency period between both batches was recorded. All lesions induced in the control batch were malignant, whereas only 45% of those induced in TAM-treated animals were malignant and the remaining 55% were preneoplastic. At 60 days after treatment discontinuance, tumor incidence increased to 90% and also tumor number per rat increased to 4.6 +/- 1.5. TAM effect was also evaluated in rats with NMU-induced tumors by treatment with 1 mg/kg per day during 60 days starting when tumors reached a 1.5-cm diameter. Regression to less than 80% of initial size in 49% of the tumors was observed, while in ovariectomized rats, 33% of tumors regressed. Estrogen receptor content, ER (fmol/mg protein) and Kd (nM) in control tumors were: 56 +/- 10 and 0.5 +/- 0.1. In tumors of TAM-treated animals, ER was less than 5 fmol/mg protein. Findings demonstrate that TAM significantly decreased the appearance of tumors induced in rats by i.p. injection of NMU and when TAM treatment was initiated after tumor induction, some tumors failed to respond to hormonal manipulation. Differential tumor growth response after TAM or oophorectomy in each tumor indicates that in the same rat it is possible to distinguish hormone-dependent and hormone-autonomous tumor populations. Hormonal regulation of tumor growth can be under intrinsic control, regardless of the hormonal status of the whole organism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620446     DOI: 10.1016/0304-3835(95)04091-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

Review 1.  N-Methyl-N-nitrosourea as a mammary carcinogenic agent.

Authors:  Ana I Faustino-Rocha; Rita Ferreira; Paula A Oliveira; Adelina Gama; Mário Ginja
Journal:  Tumour Biol       Date:  2015-09-19

2.  Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells.

Authors:  Gunjan Gakhar; Duy H Hua; Thu Annelise Nguyen
Journal:  Anticancer Drugs       Date:  2010-01       Impact factor: 2.248

3.  Cell cycle and anti-estrogen effects synergize to regulate cell proliferation and ER target gene expression.

Authors:  Mathieu Dalvai; Kerstin Bystricky
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

4.  Anti-apoptotic effect of claudin-1 in tamoxifen-treated human breast cancer MCF-7 cells.

Authors:  Harue Akasaka; Fuyuki Sato; Satoko Morohashi; Yunyan Wu; Yang Liu; Jun Kondo; Hiroki Odagiri; Kenichi Hakamada; Hiroshi Kijima
Journal:  BMC Cancer       Date:  2010-10-12       Impact factor: 4.430

5.  Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231.

Authors:  Mariel Núñez; Vanina Medina; Graciela Cricco; Máximo Croci; Claudia Cocca; Elena Rivera; Rosa Bergoc; Gabriela Martín
Journal:  BMC Pharmacol Toxicol       Date:  2013-01-11       Impact factor: 2.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.